These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31689908)

  • 1. Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?
    Christensen L; Turner JR; Peterson GM; Naunton M; Thomas J; Yee KC; Kosari S
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31689908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Patients At-Risk of QT Interval Prolongation during Medication Reviews: A Missed Opportunity?
    Buss VH; Lee K; Naunton M; Peterson GM; Kosari S
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30544669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].
    Vandael E; De WuLf I; Foulon V
    J Pharm Belg; 2016 Dec; (4):14-23. PubMed ID: 30281244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
    Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
    Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Orders for QTc-Prolonging Medication for Intensive and Cardiac Care Unit Patients with Pre-existing QTc Prolongation (QTIPPP Study).
    Mabasa VH; Yokoyama S; Man D; Martyn J
    Can J Hosp Pharm; 2011 Nov; 64(6):412-8. PubMed ID: 22479096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients.
    Khan Q; Ismail M; Haider I; Ali Z
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):109-115. PubMed ID: 29458991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
    Das B; Rawat VS; Ramasubbu SK; Kumar B
    Therapie; 2019 Dec; 74(6):599-609. PubMed ID: 31053339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of the risk factors for QT interval prolongation and associated drug-drug interactions in coronary care units.
    Khan Q; Ismail M; Haider I
    Postgrad Med; 2018 Nov; 130(8):660-665. PubMed ID: 30145917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.
    Vandael E; Marynissen T; Reyntens J; Spriet I; Vandenberghe J; Willems R; Foulon V
    Int J Clin Pharm; 2014 Aug; 36(4):757-65. PubMed ID: 24805801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Drug-Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients.
    Hefner G; Hahn M; Hiemke C; Toto S; Wolff J; Roll SC; Klimke A
    J Neural Transm (Vienna); 2021 Feb; 128(2):243-252. PubMed ID: 33417009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
    Fan W; Liu H; Shen Y; Hong K
    Cardiovasc Drugs Ther; 2024 Jun; 38(3):517-525. PubMed ID: 36625987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease.
    Assimon MM; Wang L; Pun PH; Winkelmayer WC; Flythe JE
    J Am Heart Assoc; 2020 Jul; 9(13):e015969. PubMed ID: 32578475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top 20 drug - drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients.
    Das B; Ramasubbu SK; Kumar B; Rawat VS
    J Family Med Prim Care; 2020 Dec; 9(12):6023-6040. PubMed ID: 33681037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.